This dietary supplement is recommended to protect the joints of large dog breeds
Reig Jofre, a pharma company listed on the Spanish stock market, has acquired Bioiberica’s portfolio of specialized joint health finished pharmaceutical products and nutraceuticals for the treatment of arthrosis and other arthropathies. It is also expanding its product portfolio with medicines and health products based on chondroitin sulfate, glucosamine sulfate, the combination of both and hyaluronic acid, among which are leading brands in the Spanish market and widely-known by prescribers and patients, and which enjoy a strong presence in European markets such as France, Finland and Portugal.
World regulators are cautious about crude heparin after China-made APIs were responsible for dozens of deaths in the U.S. more than a decade ago. Now, European regulators are banning heparin from a Chinese facility after finding contamination risks.
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) issued final guidance Wednesday to aid manufacturers in reducing the risk of patient injury associated with heparin-containing medical devices and combination products.
Ultragenyx’ Mepsevii has been cleared for use in Europe to treat the ultra rare disease mucopolysaccharidosis type VII (MPS VII), offering patients an approved treatment for the very first time.
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), and its ophthalmology-focused ImprimisRx division, today announced its participation and related physician presentations at the 2018 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held at the Walter E. Washington Convention Center in Washington, DC, April 13-17. The company will join the largest U.S. meeting that integrates a scientific program dedicated to the needs of anterior segment specialists, practice management staff, and ophthalmic technicians and nurses.
The Journal Annals of the Rheumatic Diseases Confirms the Efficacy of Combined Therapy with Chondroitin Sulfate Plus Glucosamine in Knee Osteoarthritis